MARMIROLI, PAOLA LORENA
 Distribuzione geografica
Continente #
NA - Nord America 12.831
EU - Europa 6.274
AS - Asia 2.710
Continente sconosciuto - Info sul continente non disponibili 17
OC - Oceania 17
SA - Sud America 13
AF - Africa 11
Totale 21.873
Nazione #
US - Stati Uniti d'America 12.565
DE - Germania 1.192
CN - Cina 1.122
SE - Svezia 1.090
IT - Italia 978
IE - Irlanda 861
UA - Ucraina 654
SG - Singapore 652
RU - Federazione Russa 475
VN - Vietnam 378
GB - Regno Unito 361
HK - Hong Kong 279
CA - Canada 257
AT - Austria 170
FI - Finlandia 155
FR - Francia 112
DK - Danimarca 99
IN - India 85
TR - Turchia 47
JP - Giappone 44
NL - Olanda 41
ID - Indonesia 34
KR - Corea 25
BE - Belgio 20
EU - Europa 16
AU - Australia 13
PL - Polonia 12
IR - Iran 11
MY - Malesia 10
BR - Brasile 9
CZ - Repubblica Ceca 9
ES - Italia 9
RO - Romania 9
BG - Bulgaria 7
TW - Taiwan 7
MX - Messico 6
GR - Grecia 5
EG - Egitto 4
NZ - Nuova Zelanda 4
RS - Serbia 4
CH - Svizzera 3
IL - Israele 3
NO - Norvegia 3
TH - Thailandia 3
AZ - Azerbaigian 2
CL - Cile 2
GT - Guatemala 2
HR - Croazia 2
NG - Nigeria 2
PE - Perù 2
PK - Pakistan 2
SC - Seychelles 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
AL - Albania 1
EE - Estonia 1
IQ - Iraq 1
KW - Kuwait 1
KZ - Kazakistan 1
MA - Marocco 1
PA - Panama 1
PH - Filippine 1
PT - Portogallo 1
SA - Arabia Saudita 1
TZ - Tanzania 1
ZA - Sudafrica 1
Totale 21.873
Città #
Ann Arbor 2.915
Woodbridge 1.169
Houston 1.014
Chandler 864
Dublin 839
Fairfield 808
Frankfurt am Main 757
Wilmington 705
Jacksonville 694
Ashburn 551
Dearborn 518
Singapore 475
Milan 386
New York 346
Princeton 328
Seattle 306
Hong Kong 279
Cambridge 271
Nanjing 214
Dong Ket 207
Boardman 190
Vienna 168
Altamura 131
Shanghai 124
Beijing 115
Lachine 111
Lawrence 109
Guangzhou 87
Santa Clara 81
Nanchang 73
Grafing 67
Toronto 64
Shenyang 60
San Diego 57
Andover 47
Fremont 46
Ottawa 46
Hebei 44
Jiaxing 43
Jinan 40
Hangzhou 38
Helsinki 38
Falls Church 36
Jakarta 33
Los Angeles 32
Changsha 31
Sacramento 31
Carate Brianza 30
Tianjin 30
Detroit 29
Pune 29
Norwalk 28
Kunming 27
Dallas 26
Edmonton 22
Huizen 22
Shangdi 22
Mountain View 21
Nürnberg 21
Zhengzhou 21
Hefei 20
Rome 19
Chicago 18
Brussels 17
Tokyo 16
Ningbo 15
Taizhou 15
London 14
Auburn Hills 12
Codroipo 12
Kiev 11
San Mateo 11
Kraków 9
Leawood 9
Mainz 9
Bergamo 8
Fuzhou 8
Melzo 8
Paris 8
Tappahannock 8
Cagliari 7
Canazei 7
Lissone 7
Munich 7
Piemonte 7
Redmond 7
Regensburg 7
Sesto San Giovanni 7
Somma Lombardo 7
Changchun 6
Chengdu 6
Daejeon 6
Monmouth Junction 6
Perugia 6
Philadelphia 6
Phoenix 6
University Park 6
Varese 6
Washington 6
Zanica 6
Totale 16.292
Nome #
In vivo comparative study on acute and sub-acute biological e_ects induced by ultrafine particles of different anthropogenic sources in balb/c mice 368
Age-related changes in the function and structure of the peripheral sensory pathway in mice 289
High-dose intravenous immunoglobulins reduce nerve macrophage infiltration and the severity of bortezomib-induced peripheral neurotoxicity in rats 288
Chemotherapy-induced peripheral neurotoxicity in the era of pharmacogenomics 287
Susceptibility of different mouse strains to oxaliplatin peripheral neurotoxicity: Phenotypic and genotypic insights 270
Extracorporeal photochemotherapy reduces the severity of Lewis rat experimental allergic encephalomyelitis through a modulation of the function of peripheral blood mononuclear cells 269
Systemic exposure to air pollution induces oxidative stress and inflammation in mouse brain, contributing to neurodegeneration onset 265
An integrative approach to cisplatin chronic toxicities in mice reveals importance of organic cation-transporter-dependent protein networks for renoprotection 253
Neuropathic pain is reduced in acid sphingomyelinase deficient mice. 229
Chemotherapy-induced peripheral neurotoxicity in immune-deficient mice: New useful ready-to-use animal models 229
Functional Magnetic Resonance Imaging of Rats with Experimental Autoimmune Encephalomyelitis Reveals Brain Cortex Remodeling 225
Role of Organic Transporters 1 and 2 in Cisplatin mediated neurotoxicity 220
Neurofilament light chain: a specific serum biomarker of axonal damage severity in rat models of Chemotherapy-Induced Peripheral Neurotoxicity 208
Morphological and morphometric analysis of paclitaxel and docetaxel-induced peripheral neuropathy in rats 202
Age and Sex Influence the Neuro-inflammatory Response to a Peripheral Acute LPS Challenge 198
Effect on the peripheral nervous system of systemically administered dimethylsulfoxide in the rat: a neurophysiological and pathological study 195
Calmangafodipir reduces sensory alterations and prevents intraepidermal nerve fibers loss in a mouse model of oxaliplatin induced peripheral neurotoxicity 193
Neuronopathies and polyneuropathies: a ready to use translational neurophysiological protocol in rodent models 192
Topiramate prevents oxaliplatin-related axonal hyperexcitability and oxaliplatin induced peripheral neurotoxicity 192
Bortezomid-induced peripheral neurotoxicity: A neurophysiological and pathological study in the rat. 189
Histological features of nerve fibers and endoneural vessels in a case of Wegener's granulomatosis. 182
Effect of recombinant human nerve growth factor on cisplatin neurotoxicity in rats 181
Human Intravenous Immunoglobulin Alleviates Neuropathic Symptoms in a Rat Model of Paclitaxel-Induced Peripheral Neurotoxicity 180
Bortezomib-induced painful neuropathy in rats: a behavioral, neurophysiological and pathological study in rats 178
Treatment of patients with neuropathy and anti-MAG IgM M-proteins. 176
Pain in chemotherapy-induced peripheral neurotoxicity 176
Neurofilament light chain as disease biomarker in a rodent model of chemotherapy induced peripheral neuropathy 176
Effects of Manidipine and Delapril in Hypertensive Patients With Type 2 Diabetes Mellitus: The Delapril and Manidipine for Nephroprotection in Diabetes (DEMAND) Randomized Clinical Trial 175
Study of perpheral neurotoxicity of different doses of oxaliplatin in cd1 mice 174
CR4056, a new analgesic I2 ligand, is highly effective against bortezomib-induced painful neuropathy in rats 173
The relevance of multimodal assessment in experimental oxaliplatin-induced peripheral neurotoxicity 172
Nerve Excitability Testing to Unravel Chemotherapy Induced Peripheral Neurotoxicity (CIPN) Pathogenesis: Altered Axonal Excitability as a Possible Pivotal Event Related to Platinum Compounds and Taxanes 169
Assessment of oxaliplatin-induced peripheral neurotoxicity with different treatment schedules 169
The ventral caudal nerve: a physiologic-morphometric study in three different rat strains 168
A large-field polarisation-resolved laser scanning microscope: Applications to CARS imaging 168
Ultrastructural organization of lamina VI of the spinal cord of the cat. 166
A clinico-pathological and follow up study of 10 cases of essential type II cryoglobulinaemic neuropathy 165
Oxidative stress and inflammation induced by acute and subacute ultrafine exposure: contrinbution to alzheimer's disease 164
Cisplatin-induced peripheral neurotoxicity in rats reduces the circulating levels of nerve growth factor 162
Lipid-free versus lipid-bound P2 protein-induced experimental allergic neuritis: Clinicopathological, neurophysiological, and immunological study 161
OCT2 transporter involvement in development of cisplatin toxicity 161
Expression, distribution and glutamate uptake activity of high affinity-excitatory aminoacid transporters in in vitro cultures of embryonic rat dorsal root ganglia 161
Islet transplantation and insulin administration relieve long-term complications and rescue the residual endogenous pancreatic β cells 159
Anti-myelin-associated glycoprotein IgM antibody titers in neuropathy associated with macroglobulinemia. 158
Sensory-motor paclitaxel polyneuropathy characterization in a rat model 158
Effects of different erythropoietin schedules in cisplatin-induced peripheral neurotoxicity 157
Morphometric study of the sensory neuron and peripheral nerve changes induced by chronic cisplatin (DDP) administration in rats 157
Platinum-taxane combination chemotherapy: General and peripheral neurotoxicity of their combined administration in the rat 155
Peripheral neuropathy in monoclonal gammopathy of undetermined significance: prevalence and immunopathogenetic studies 155
Cryoglobulinaemic neuropathy: lack of progression in patients with good haematological control 155
Current view in platinum drug mechanisms of peripheral neurotoxicity 154
Neurophysiological and neuropathological characterization of new murine models of chemotherapy-induced chronic peripheral neuropathies 153
Peripheral nervous system involvement in Niemann-Pick disease type 152
Platinum-Taxane combination chemotherapy: assessment of electrophysiologic pathologic and morphometric fetures in chronic wistar rat models 152
Neurotoxicity of oxaliplatin (I-OHP) in rats and influence of scheduling 151
Neurotrophin effect on the SH-SY5Y human neuroblastoma (HN) model of CDDP-induced neurotoxicity 151
Distribution of paclitaxel within the nervous system of the rat after repeated intravenous administration 149
Effects induced by particles derived from two anthropogenic sources on respiratory, cardiovascular and central nervous systems 149
Intraepidermal nerve fiber density in rat foot pad: neuropathologic-neurophysiologic correlation 148
Focus on the role of Glutamate in the pathology of the peripheral nervous system 146
Bortezomib-induced peripheral neurotoxicity: A neurophysiological study in a rat model 144
EVALUATION OF THE EFFICACY OF PERIPHAGEN NEUROTROPHIN-3 EXPRESSING VECTOR FOR OXALIPLATIN INDUCED PERIPHERAL NEUROPATHY. 144
Reply to a comment paper on the published paper by canta, a. Et al: “calmangafodipir reduces sensory alterations and prevents intraepidermal nerve fibers loss in a mouse model of oxaliplatin induced peripheral neurotoxicity”—antioxidants 2020, 9, 594 144
Platinum-taxane combination chemotherapy: Description of the first study to assess the general and peripheral neurotoxicity of their combined administration in the rat 143
Circulating nerve growth factor level changes during oxaliplatin treatment-induced neurotoxicity in the rat 143
Transplanted pancreatic islets survive and reverse type I diabetic neuropathy 143
Chemotherapy-induced peripheral neurotoxicity 142
Drugs for the treatment of peripheral neuropathies 142
Animal Models for the Study of Human Central and Peripheral Nervous System Diseases 141
Anti-sulfatide IgM antibodies in peripheral neuropathy 140
Cisplatin-induced DNA-platination in experimental dorsal root ganglia neuronopathy 137
Chemotherapy-induced peripheral neurotoxicity in cancer survivors: an underdiagnosed clinical entity? 137
The Role of Oxidative Stress and Anti-Oxidant Treatment in Platinum-Induced Peripheral Neurotoxicity 136
Peripheral neuropathy in macroglobulinemia: incidence and antigen-specificity of M proteins. 136
Murine neural stem cells model Hunter disease in vitro: glial cell-mediated neurodegeneration as a possible mechanism involved 134
Intravenous Immunoglobulin Preparation Attenuates Pain Behaviors in a Wistar Rat Model of Bortezomib-Induced Peripheral Neuropathy 134
Pharmacotherapy options for managing chemotherapy-induced peripheral neurotoxicity 134
Sialidosis type I: pathological study in an adult. 131
Topiramate Prevents Oxaliplatin Neurotoxicity in a rat model 130
Effects of repeated administration of low doses of cisplatin on the rat nervous system. 128
The fundamental role of morphology in experimental neurotoxicology: the example of chemotherapy-induced peripheral neurotoxicity 128
Expression and distribution of 'high affinity' glutamate transporters GLT1, GLAST, EAAC1 and of GCPII in the rat peripheral nervous system 127
Bortezomib-induced peripheral neurotoxicity in human multiple myeloma-bearing mice 127
Neurotrophins: effect on cisplatin-induced cytotoxicity and neurotoxicity in SH-SY5Y cells 127
Morphology meets function to unravel Oxaliplatin Induced Peripheral Neurotoxicity (OIPN) 125
Proteasome inhibition: a promising strategy for treating cancer, but what about neurotoxicity? 124
Ethoxyquin provides neuroprotection against cisplatin-induced neurotoxicity 124
Multimodal experimental approach to the study of human neurological diseases 124
A Possible role of OCT2 gene in the development of peripheral neurotoxicity induced by cisplatin 124
The role of growth factors in the prevention and treatment of chemotherapy-induced peripheral neurotoxicity 123
Ethoxyquin is effective in preventing cisplatin-induced painful peripheral neuropathy in rats 122
Effect of preventive and therapeutic treatment of ghrelin agonist HM01 on the peripheral neurotoxicity induced by bortezomib in wistar rats. 122
Imunohystochemical characterization of the distribution of glutamate receptors, “high affinity” membrane bound glutamate transporters and of Glutamate Carboxipeptidase II (GCPII) in in vitro cultures of embryonic dorsal root ganglia. 121
NERVE EXCITABILITY TESTING AS THE LINK BETWEEN ANATOMY AND PHYSIOLOGY: AXONAL EXCITABILITY TESTING TO TEST IN VIVO MECHANISMS OF PERIPHERAL NERVE DAMAGE. 121
Tackling Oxaliplatin Induced Peripheral neurotoxicity: from bed to bench side and back. 121
Neurotoxic effects of antineoplastic drugs: the lesson of pre-clinical studies 119
The Glutamatergic Neurotransmission in the Central Nervous System 119
Tissue Distribution of Glutamate Carboxypeptidase II (GCPII) with a Focus on the Central and Peripheral Nervous System 118
Bortezomib treatment produces nocifensive behavior and changes in the expression of TRPV1, CGRP, and substance P in the rat DRG, spinal cord, and sciatic nerve 118
The severity of oxaliplatin neurotoxicity is related to differential expression of a solute transporter in mice 118
Totale 16.492
Categoria #
all - tutte 69.703
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 69.703


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20203.338 0 0 289 270 387 511 605 274 371 297 258 76
2020/20213.819 167 146 460 379 295 311 377 331 312 302 200 539
2021/20222.152 161 223 234 242 155 240 108 95 91 123 138 342
2022/20233.624 398 1.018 372 368 278 575 53 157 255 36 56 58
2023/20242.673 98 88 110 93 334 650 521 140 158 42 37 402
2024/20251.202 390 809 3 0 0 0 0 0 0 0 0 0
Totale 23.115